logo

For the Inventor, By the Inventor

Tokushima, Japan

Yoshihiro Ooi

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Ostuka Pharmaceutical Co., Ltd.. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiro Ooi. Retrieved from https://idiyas.com/inventor/yoshihiro-ooi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 50.0


Average Co-Inventor Count = 19.0

ph-index = 5

Forward Citations = 116(Granted Patents)


Company Filing History:

goldMedal11 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents
silverMedal1 out of 2 
 
Ostuka Pharmaceutical Co., Ltd.
 patents

Years Active: 2011-2018

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 10150735 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2018-12-11),
2. 9359302 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2016-06-07),
3. 8993761 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2015-03-31),
4. 8901303 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-12-02),
5. 8901130 - Low hygroscopic aripiprazole drug substance and processes for the preparation (2014-12-02),
6. 8703773 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-04-22),
7. 8703772 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-04-22),
8. 8642760 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-02-04),
9. 8580796 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2013-11-12),
10. 8399469 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2013-03-19),
11. 8017615 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2011-09-13),
12. 7910589 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2011-03-22),

Title: The Innovations of Yoshihiro Ooi

Introduction

Yoshihiro Ooi is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of low hygroscopic drug substances. With a total of 12 patents to his name, Ooi's work has had a substantial impact on medicinal preparations.

Latest Patents

One of his latest patents is focused on low hygroscopic forms of aripiprazole and the processes for their preparation. This invention ensures that the drug substance does not convert to a hydrate or lose its original solubility, even when stored for extended periods. This advancement is crucial for maintaining the efficacy of medicinal preparations containing anhydrous aripiprazole crystals.

Career Highlights

Throughout his career, Yoshihiro Ooi has worked with notable companies, including Otsuka Pharmaceutical Company, Limited and Otsuka Pharmaceutical Co. Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Ooi has collaborated with several professionals in his field, including Takuji Bando and Satoshi Aoki. These partnerships have contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Yoshihiro Ooi's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving drug formulations. His work continues to influence the field and enhance the effectiveness of medicinal treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…